Skip to content

Fetal Pulse Oximetry Trial (FOX)

A Randomized Clinical Trial of Fetal Pulse Oximetry

Status
Terminated
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00098709
Enrollment
10000
Registered
2004-12-08
Start date
2002-05-31
Completion date
2005-02-28
Last updated
2022-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

pregnancy, labor, obstetric, fetal monitoring, oximetry, fetal heart rate, cardiotocography

Brief summary

The purpose of this study is to determine if the information provided to the physician by a fetal pulse oximeter during labor will reduce the chances of a cesarean delivery.

Detailed description

Information on fetal well-being during labor is of great importance to the managing physician. The current use of the fetal heart rate monitor provides some information on fetal condition, and is the primary tool used to determine if immediate operative delivery is required. The fetal pulse oximeter can provide additional information regarding fetal oxygen saturation. Intervention: A fetal oxygen saturation sensor is placed in the uterus, between the fetal cheek or forehead and the uterine wall. In half of the patients, the managing physician will have access to fetal oxygen saturation and fetal heart rate monitoring. In the other half of the patients, labor will be monitored by fetal heart rate alone. Study hypothesis: The additional information provided by the use of the fetal pulse oximeter will reduce the chances of a cesarean delivery. The primary outcome is cesarean section for any indication and secondary outcomes are cesarean delivery for non-reassuring fetal heart rate or dystocia, and neonatal morbidity.

Interventions

DEVICEFetal pulse oximeter

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
CollaboratorNIH
The George Washington University Biostatistics Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Nulliparous * Singleton, cephalic pregnancy * Gestational age at least 36 weeks, 0 days * Cervical dilatation \>= 2 cm * Station -2 or below (5ths scale) * Ruptured membranes * Internal monitoring devices placed

Exclusion criteria

* Need for immediate delivery * Planned cesarean delivery * Cervical dilatation \> 6 cm * Known fetal anomaly or demise * Multifetal gestation * Maternal fever * Placenta previa * Previous uterine surgery * Active HSV infection * Known HIV or hepatitis infection * Diabetes requiring insulin * Heart disease requiring medication * Known chronic renal disease * Enrollment in another labor study

Design outcomes

Primary

MeasureTime frame
cesarean delivery (any indication)

Secondary

MeasureTime frame
cesarean delivery for non-reassuring fetal heart rate
cesarean delivery for dystocia
neonatal morbidity

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 8, 2026